What is the difference between the ischemic core and the penumbra?

The core is tissue where blood flow is so low that infarction is rapid and irreversible, while the penumbra is surrounding tissue that is functionally impaired but still viable for a limited time. The penumbra is the target of reperfusion strategies.

How is ischemic stroke different from a transient ischemic attack?

Both arise from ischemia, but ischemic stroke involves demonstrable infarction of tissue, whereas a transient ischemic attack is transient ischemia without lasting infarction under the modern tissue-based definition.

Ischemic Stroke

Ischemic stroke is an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction following occlusion or critical narrowing of a supplying artery. It is the most common stroke subtype and a leading cause of disability, defined by tissue injury and shaped by the concept of a salvageable penumbra surrounding an irreversibly damaged core.

Definition

Ischemic stroke is central nervous system infarction, an episode of focal neurological dysfunction caused by infarction of brain, spinal cord, or retinal tissue resulting from arterial occlusion or critical hypoperfusion, with demonstrable tissue injury rather than symptom duration as the defining feature.

Scope

This entry defines ischemic stroke, outlines its principal mechanisms and the ischemic core-penumbra model, introduces common etiologic classification, and orients the reader to the time-critical logic of acute care. It is a reference and educational overview and does not provide diagnostic or treatment recommendations for any individual.

Core questions

What distinguishes the ischemic core from the penumbra, and why does it matter?
What are the major causes of arterial occlusion leading to infarction?
How is ischemic stroke classified by mechanism?
Why is ischemic stroke treated as a time-critical emergency?

Key concepts

Cerebral infarction
Ischemic core and penumbra
Large-vessel versus small-vessel occlusion
Cardioembolism (e.g., atrial fibrillation)
Atherosclerosis and artery-to-artery embolism
TOAST etiologic classification
Reperfusion (thrombolysis and thrombectomy) as research-established strategies
'Time is brain'

Mechanisms

Ischemic stroke begins when a cerebral artery is occluded, most often by thrombosis on an atherosclerotic plaque, by an embolus from the heart or a proximal artery, or by small-vessel (lacunar) disease. Loss of blood flow deprives tissue of oxygen and glucose; the central core where flow is lowest undergoes rapid, irreversible infarction, while a surrounding penumbra remains electrically silent but metabolically viable for a limited time and is the target of reperfusion. The modern definition anchors the diagnosis to demonstrable infarction (Sacco et al., 2013). Time-sensitive reperfusion underlies the established acute strategies of intravenous thrombolysis (NINDS rt-PA Stroke Study Group, 1995) and, for large-vessel occlusion, endovascular thrombectomy (Berkhemer et al., 2015; Goyal et al., 2016).

Clinical relevance

Understanding the mechanisms and classification of ischemic stroke supports critical reading of the cerebrovascular literature and of evidence on acute reperfusion and prevention. This entry describes how ischemic stroke is characterized and studied; it is not a basis for diagnosis or treatment of an individual, which depends on clinical assessment, imaging, eligibility criteria, and current guidelines and rests with the treating team (Powers et al., 2019).

Epidemiology

Ischemic stroke is the most common stroke subtype in most populations and a major cause of long-term disability. Incidence rises steeply with age, and risk is shaped by hypertension, atrial fibrillation, diabetes, smoking, and atherosclerotic burden. Broad reviews summarize the global scale and risk-factor profile of the condition (Hankey, 2017).

Evidence & guidelines

The tissue-based definition is set out by Sacco et al. (2013). Landmark trials established intravenous thrombolysis (NINDS rt-PA Stroke Study Group, 1995) and, for large-vessel occlusion, endovascular thrombectomy, the latter consolidated by a pooled individual-patient meta-analysis (Berkhemer et al., 2015; Goyal et al., 2016). Acute management is summarized in AHA/ASA early-management guidance (Powers et al., 2019).

History

For much of the twentieth century, acute ischemic stroke had no proven time-critical therapy. The NINDS trial (1995) established that intravenous tissue plasminogen activator given early could improve outcomes, opening the era of acute reperfusion. Two decades later, a series of randomized trials and their pooled meta-analysis demonstrated the benefit of endovascular thrombectomy for large-vessel occlusion (Berkhemer et al., 2015; Goyal et al., 2016), and the tissue-based redefinition of stroke reframed the diagnosis around demonstrable infarction (Sacco et al., 2013).

Debates

How should the treatment time window be defined?: Early trials used fixed time windows from symptom onset, but imaging of the salvageable penumbra has shifted attention toward tissue-based selection that may extend eligibility for some patients; how best to select patients beyond standard windows remains an active research question.

Key figures

Ralph L. Sacco
Olvert A. Berkhemer
Mayank Goyal
Werner Hacke

Seminal works

sacco-2013
ninds-1995
berkhemer-2015
goyal-2016

Frequently asked questions

What is the difference between the ischemic core and the penumbra?: The core is tissue where blood flow is so low that infarction is rapid and irreversible, while the penumbra is surrounding tissue that is functionally impaired but still viable for a limited time. The penumbra is the target of reperfusion strategies.
How is ischemic stroke different from a transient ischemic attack?: Both arise from ischemia, but ischemic stroke involves demonstrable infarction of tissue, whereas a transient ischemic attack is transient ischemia without lasting infarction under the modern tissue-based definition.